Targeted Therapy for Metastatic Renal Carcinoma: an Update

Conventional chemotherapy is associated with poor outcomes in metastatic renal cell carcinoma (RCC). Advances in the understanding of tumor molecular biology and the implementation of new drugs that target these molecular pathways have increased the arsenal against advanced RCC and improved outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Rodrigo Donalisio, Gustafson, Diedra, Nogueira, Leticia, Werahera, Priya N., Molina, Wilson R., Kim, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Codon Publications 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345523/
https://www.ncbi.nlm.nih.gov/pubmed/28326251
http://dx.doi.org/10.15586/jkcvhl.2014.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345523/
https://www.ncbi.nlm.nih.gov/pubmed/28326251
http://dx.doi.org/10.15586/jkcvhl.2014.14

Ejemplares similares